AD
Publicaties op Oncologisch.com
INDUCE-3: A Gerandomiseerde Fase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent...
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with s...
Nivolumab-ipilimumab versus EXTREME bij recidief hoofd-halscarcinoom: CheckMate 651 fase III
Durvalumab met of zonder tremelimumab bij PD-L1-laag/negatief recidief hoofd-halscarcinoom: CONDOR